Cystic Fibrosis in Korean Children: A Case Report Identified by a Quantitative Pilocarpine Iontophoresis Sweat Test and Genetic Analysis by Ahn, Kang-Mo et al.
INTRODUCTION
Cystic fibrosis (CF) is a lethal genetic disorder, which man-
ifests a variety of symptoms such as chronic productive cough,
respiratory difficulty, meconium ileus, malabsorption, failure
to thrive, infertility, etc. CF is caused by the mutations in cys-
tic fibrosis transmembrane conductance regulator (CFTR)
gene located on the long arm of chromosome 7, and over 1000
mutations in this gene have been described to date (1). CFTR
gene encodes a 1,480 amino acid polypeptide, which functions
mainly as a chloride channel in epithelial cells of lung, sinuses,
pancreas, liver and reproductive tract. The diagnosis of CF
is made by several findings, which include the presence of
typical clinical features, a history of CF in a sibling, positive
sweat test, identification of CFTR mutations in both alleles
and an abnormal nasal potential difference measurement (2).
CF is common in Caucasians, especially in Northern and
Central Europeans, with an incidence of 1/2000-1/3000 new-
borns (3). In contrast, CF occurs rarely in Asian populations,
as suggested by the previous data in which the incidence of
CF was 1/90,000 in Asian infants in Hawaii (4) and about
1/350,000 in Japanese population (5). Until recently, there-
fore, sweat test has not been established in Korea due to its
low incidence, leading to underdiagnosis of this disease even
in suspected cases. Up to now only one case of CF was reported
in Korea (6). However, this case was diagnosed by using a
similar method described by di Sant’Agnese et al. (7), not by
a quantitative pilocarpine iontophoresis sweat test, and the
DNA analysis was not performed. 
Recently, we experienced two Korean girls with CF iden-
tified by a quantitative pilocarpine iontophoresis sweat test
and the genetic analysis. We herein present these cases with
a review of the literatures.
CASE REPORT
Case 1
A 9 yr-old girl was admitted to Samsung Medical Center
due to chronic productive cough and shortness of breath. Dur-
ing the infancy she developed cough and sputum, which was
associated with frequent respiratory tract infection. Diarrhea
persisted from 1 month of age regardless of the dietary for-
mula and is unresponsive to antibiotics. Diarrhea led to poor
weight gain and generalized edema, which necessitates hos-
pitalization twice. Mantoux test performed at 10 months of
her age because of chronic cough was positive (15×15 mm).
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Cystic Fibrosis in Korean Children: A Case Report Identified by a
Quantitative Pilocarpine Iontophoresis Sweat Test and Genetic Analysis
Cystic fibrosis (CF) is inherited as an autosomal recessive trait, and the mutations
in cystic fibrosis transmembrane conductance regulator (CFTR) gene contributes
to the CF syndrome. Although CF is common in Caucasians, it is known to be rare
in Asians. Recently, we experienced two cases of CF in Korean children. The patients
were girls with chronic productive cough since early infancy. Chest computed tomog-
raphy showed the diffuse bronchiectasis in both lungs, and their diagnosis was con-
firmed by the repeated analysis of a quantitative pilocarpine iontophoresis test (QPIT).
The sweat chloride concentrations of the first patient were 108.1 mM/L and 96.7
mM/L. The genetic analysis revealed that she was the compound heterozygote of
Q1291X and IVS8 T5-M470V. In the second case, the sweat chloride concentrations
were 95.0 mM/L and 77.5 mM/L. Although we performed a comprehensive search
for the coding regions and exon-intron splicing junctions of CFTR gene, no obvious
disease-related mutations were detected in the second case. To our knowledge, this
is the first report of CF in Korean children identified by a QPIT and genetic analysis.
The possibility of CF should be suspected in those patients with chronic respiratory
symptoms even in Korea.
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Hence she was treated with anti-tuberculosis regimen for 9
months, but her symptoms did not improve. When she was
2 yr old, clubbing fingers were noticed, and at 5 yr of age,
she received ventilator care due to severe respiratory distress.
At that time, Pseudomonas aeruginosa was isolated from her spu-
tum. Since then, her respiratory symptoms were waxed and
waned, and she had been hospitalized several times. 
She was born by vaginal delivery without any perinatal prob-
lems. Her birth weight was 2.4 kg, which was small for her
gestational age (37 weeks). Vaccination was done as scheduled.
She had a 7-yr old younger brother, and family history was
unremarkable. Besides chronic productive cough and respi-
ratory difficulty, she complained of the intermittent abdom-
inal pain or chest discomfort. She also presented diarrhea after
fat-rich meal. Other symptoms were denied.
On admission, her blood pressure was 104/49 mmHg, heart
rate 90 beats/min, respiratory rate 26/min and the body tem-
perature 37℃. Her body weight was 19.1 kg (<3 percentile)
and her height was 118 cm (<3 percentile). She had chronic
ill-looking appearance and her mentality was alert. Both chest
walls expanded symmetrically with mild intercostal retrac-
tion. Coarse breathing sound and crackles were heard on both
lung fields. The heart beats were regular and murmur was
not heard. There was hepatomegaly but the spleen was not
palpable. Clubbing fingers were noted with cyanosis. There
was no specific finding on neurologic examination.
The diseases such as immunodeficiency, allergic disease,
congenital heart disease and ciliary dyskinesia were ruled out
by her normal complete blood cell count (CBC), serum immu-
noglobulin levels, specific IgE levels, echocardiogram and
bronchial mucosal biopsy. Stool examination showed 30 neu-
tral fat droplets and 60 fatty acid droplets per high power
field. Chest and abdomen computed tomography (CT) scan
demonstrated the bronchiectasis in both lung fields (Fig. 1A,
B) and fatty replacement of pancreas with severe atrophy (Fig.
1C). Inflammatory change in maxillary, frontal, ethmoid sinus-
es and polyposis in the right maxillary sinus were found in
CT scan of paranasal sinuses. P. aeruginosa was cultured from
her sputum. 
The sweat chloride concentration was measured by a quan-
titative pilocarpine iontophoresis sweat test recommended
by National Committee for Clinical Laboratory Standards
(National Committee for Clinical Laboratory Standards. Sweat
Testing: Sample Collection and Quantitative Analysis: Approv-
ed Guideline. Villnova, Pa: National Committee for Clinical
Laboratory Standards; 1997 NCCLS document C34-A.). The
test was performed repeatedly on separate days to confirm the
diagnosis. The skin of her both forearms was stimulated with
pilocarpine and an electrical current of 4 mA for 5 min. The
sweat specimens were collected on a gauze pad for 30 min
preventing evaporation. The weight of the samples and the
chloride concentration was measured according to the mercu-
riometric titration method (8). The average weights of the
sweat samples from both forearms were 131.5 mg in the first
test and 134.5 mg in the second test. The average sweat chlo-
ride concentrations on both forearms were 108.1 mM/L and
96.7 mM/L in separate occasions performed 2 weeks interval.
Intrassay coefficients of variation ranged from 2.8-18.4% for
both forearms. Patient’s brother showed negative sweat test
(25.3 mM/L), while sweat chloride concentration of her mother
was 42.6 mM/L. Patient’s father did not perform sweat test. 
Eleven mutation/polymorphism loci of CFTR gene previ-
ously found in a Korean population and ten most common
disease-associated loci in Caucasians were screened using SNaP-
Shot method as previously detailed (9). In addition, denaturing
gradient gel electrophoresis (DGGE) and subsequent nucleo-
tide sequencings were performed to find unknown CFTR
mutations. Two disease-related mutations were identified in
this patient: Q1291X and IVS8 T5-M470V. Haplotyping
using the method described by Lee et al. (9) revealed that
the two mutations were located in different alleles. Finally,
it was identified that Q1291X was from her father and IVS8
T5-M470V was from her mother in the genetic analyses of
family members (Fig. 2). 
Fig. 1. Radiologic findings of case 1. Plain radiography (A) and computed tomography (CT) scan (B) reveal bronchiectasis. Pancreatic
atrophy is found in abdomen CT scan (C).
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Case 2
A 6 yr-old girl was admitted to Samsung Medical Center
due to chronic cough, coarse breathing sound and sputum
from 2 months of age. She was hospitalized 3 times during
the first year of her life because of recurrent bronchiolitis or
bronchial asthma. She developed rhinorrhea and nasal stuffi-
ness at 3 yr of age. Additionally she suffered from pneumonia
with sinusitis twice, which required hospitalization. At that
time, P. aeruginosa was cultured from her sputum and she was
treated with intravenous antibiotics. These respiratory symp-
toms were waxed and waned, and she was transferred for fur-
ther evaluation.
She was the full-term baby with a birth weight of 3.2 kg.
Past medical history revealed that she was sensitized to house
dust mite allergen. There was no history of chronic diarrhea,
vomiting and failure to thrive. No other symptoms were re-
ported. She had a younger brother, who was 16 months old,
and family history was not significant. She was a well-devel-
oped girl with weight and height at the 15th percentile for
age (17.5 kg, 108.5 cm). Her chest was not retracted, and
her breath sounds were slightly coarse with crackles in both
lungs. Otherwise, there were no abnormalities on physical
examination. 
The diagnostic test for her immunologic status including
CBC, immunoglobulin level, and complement level demon-
strated no abnormality. Chest roentgenogram and CT showed
diffuse bronchiectasis in the right middle lobe and both lower
lobes. The paranasal sinus CT revealed pansinusitis with poly-
posis (Fig. 3). There was no abnormality in stool examination
and pulmonary function test. P. aeruginosa was isolated from
her sputum, and nasal mucosal biopsy failed to provide sig-
nificant information because the biopsy specimens were not
adequate. The sweat test was performed repeatedly on sepa-
rate days by the same method described in the first case. Sweat
samples were collected at the average amount of 177.5 mg
and 115.5 mg, respectively. Average sweat chloride concen-
trations of both forearms were 95.0 mM/L and 77.5 mM/L,
which were performed on separate occasions over one-week
interval. Intrassay coefficients of variation of sweat chloride
of both forearms ranged from 3.8-5.0%. Sweat test was also
performed in her parents whose sweat chloride concentrations
were below 40 mM/L. 
Although we performed a comprehensive search for the
coding regions and exon-intron splicing junctions of CFTR
gene, no obvious disease-related mutations were found in this
case except for some common polymorphisms such as 2694T/
G (T854 in exon 14a), which were not supposed to contribute
to the disease phenotype (9).
DISCUSSION
Our two patients have manifested chronic productive cough
and recurrent pneumonia since their infancy, and P. aeruginosa
was isolated from their sputum specimens. These findings
are consistent with the previous reports about CF, in which
acute or persistent respiratory symptoms are the most com-
mon clinical manifestations and P. aeruginosa is the most com-
monly identified pathogen from the respiratory tract cultures
(10). Additionally, chest CT scan revealed the bronchiectasis
in both lung fields. Although gastrointestinal symptoms were
not apparent in the second patient, in contrast to the first
patient, her respiratory symptoms and signs were strongly
suggestive of CF. Their diagnosis was confirmed as late as at
the age of 9 yr for the first patient and 6 yr for the second
patient, although the median age of the diagnosis of CF is 6
months (10). Diagnosis of CF was delayed because reliable
sweat test was not available in Korea so far.
Fig. 3. CT findings, coronal view in case 2. Pansinusitis with poly-
posis is shown.
Fig. 2. Family pedigree of the disease-associated CFTR mutations
in case 1. Disease associated genetic variations are shown in bold
letters.
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Since the sweat electrolytes abnormalities in CF patients
were first described by di Sant’Agnese (11), the sweat test is
considered as the most valuable diagnostic procedure. Despite
its importance in the correct diagnosis of CF, false sweat test
results can occur by several factors such as unreliable methods,
technical errors of evaporation and contamination, the errors
in instrument calibration, and the errors in interpretation (12).
Therefore, a quantitative pilocarpine iontophoresis sweat test
has been widely used as a reliable standard method, and CF
is diagnosed by an increased chloride concentration of more
than 60 mM/L on two or more occasions. Our cases were diag-
nosed by the standardized pilocarpine iontophoresis recom-
mended by NCCLS. Although some laboratories measure
sweat sodium concentration, we do not expect additional diag-
nostic information (13). Many clinical laboratories use chlo-
ridometer for the sweat chloride test, and the mercuriometric
titration method is only performed in 8% of U.S.A. clinical
laboratories, which requires manual procedure (14). The lat-
ter can be a good alternative when the chloridometer is not
available. 
We also performed CFTR mutational analyses which sup-
ported the diagnosis. Genetic analysis is a useful diagnostic
tool, because the identification of two CFTR mutations is
highly specific despite its low sensitivity. A deletion of a single
phenylalanine residue at amino acid 508 ( F508) is the most
prevalent mutation in CF patients from North America (15).
The screening of approximately 30 mutations can detect 80-
90% CF patients in North America (2). In East Asia only 15
cases has identified CFTR mutations among more than 80
CF patients documented so far (16). Although extensive stud-
ies with a large number of CF patients from East Asia are still
lacking, the CFTR mutation spectrum seems different bet-
ween the East Asians and the Caucasians (16, 17). Indeed, a
recent analysis of CFTR gene revealed that significant num-
bers of genetic variations existed in a 192 Korean population,
of which sequences are quite different from those of Caucasians
(9). Of importance, some of the genetic variations were asso-
ciated with respiratory and pancreatic diseases. For example,
Q1352H mutation showed about 0.9% heterozygote frequen-
cies in the control Korean population and was associated with
the chronic bronchiectasis as a haplo-insufficiency form. These
results imply that considerable numbers of individuals, which
have the homozygote or compound heterozygote genotypes
of disease-beating CFTR mutations, will exist in 48 million-
sized South Korean population.
In the first case, IVS8 T5-M470V and Q1291X mutations
were identified in each allele. IVS T5variation, which decreased
the proper mRNA splicing of CFTR gene, was reported to
be highly associated with disease phenotype when joined with
the M470V polymorphism (18). Q1291X mutation evokes
the deletion of C-terminal 63 amino acids from intact CFTR
protein and also was shown to be associated with CF (19). We
could not find the disease-associated CFTR mutations in the
second case even after extensive analysis of the entire coding
regions and the exon-intron splicing junctions. Recently, an
interesting result was reported that significant proportions
of variant CF do not have CFTR mutations (20). The clinical
findings in the second case, a monosymptomatic lung patholo-
gy with the defect in sweat chloride concentration, belongs
to the category of the variant CF. Rare mutations in deep in-
tron regions or factors other than CFTR mutations may be
responsible for the disease phenotypes in the second case. 
To our knowledge, this is the first report of CF in Korean
children identified by a quantitative pilocarpine iontophoresis
sweat test and genetic analysis. Even though the molecular
diagnosis is confirmatory and helpful for the carrier detection,
it cannot be applied easily to the CF diagnosis because (1) the
reported CF mutations are over 1,000, (2) common CF muta-
tions have not been identified in Korean population, and (3)
its low cost-effectiveness. Accordingly, the standardized sweat
chloride test is recommend for the diagnosis of CF, although
10% of CF cases showed normal values (13, 21). 
In conclusion, we experienced two cases of CF. A high index
of suspicion is necessary to diagnose CF in patients with ch-
ronic respiratory symptoms even in Korea, although the inci-
dence of CF is low.
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